4//SEC Filing
VENKATARAMAN BALAJI 4
Accession 0000921895-24-000337
CIK 0001788028other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 8:40 PM ET
Size
22.1 KB
Accession
0000921895-24-000337
Insider Transaction Report
Form 4
Avego Management LLC
Other
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
VENKATARAMAN BALAJI
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
Morgan Adam
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
Velan Capital Management LLC
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2024-02-08$12.95/sh+350,000$4,532,500→ 1,188,500 total(indirect: By Velan Capital Master Fund LP)
Holdings
- 245,328(indirect: By Avego Healthcare Capital, L.P.)
Common Stock, par value $0.0001 per share
Footnotes (4)
- [F1]This Form 4 is filed jointly by Velan Capital Master Fund LP ("Velan Master"), Avego Healthcare Capital, L.P. ("Avego Fund"), Velan Capital Holdings LLC ("Velan GP"), Avego Healthcare Capital Holdings, LLC ("Avego GP"), Avego Management, LLC ("Avego Management"), Velan Capital Investment Management LP ("Velan Capital"), Velan Capital Management LLC ("Velan IM GP"), Balaji Venkataraman and Adam Morgan (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that no longer collectively beneficially owns more than 10% of the Issuer's outstanding shares. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- [F2]Securities owned directly by Velan Master. As the general partner of Velan Master, Velan GP may be deemed to beneficially own the securities owned directly by Velan Master. As the investment manager of Velan Master, Velan Capital may be deemed to beneficially own the securities owned directly by Velan Master. As the general partner of Velan Capital, Velan IM GP may be deemed to beneficially own the securities owned directly by Velan Master. As the managing members of Velan GP and Velan IM GP, Messrs. Venkataraman and Morgan may be deemed to beneficially own the securities owned directly by Velan Master.
- [F3]Securities owned directly by Avego Fund. As the general partner of Avego Fund, Avego GP may be deemed to beneficially own the securities owned directly by Avego Fund. As the co-investment manager of Avego Fund, Avego Management may be deemed to beneficially own the securities owned directly by Avego Fund. As the co-investment manager of Avego Fund, Velan Capital may be deemed to beneficially own the securities owned directly by Avego Fund. As the general partner of Velan Capital, Velan IM GP may be deemed to beneficially own the securities owned directly by Avego Fund. As the managing member of each of Avego GP, Avego Management, Velan GP and Velan IM GP, Mr. Venkataraman may be deemed to beneficially own the securities owned directly by Avego Fund. As the managing member of each of Velan GP and Velan IM GP, Mr. Morgan may be deemed to beneficially own the securities owned directly by Avego Fund.
- [F4]Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected on January 4, 2024.
Documents
Issuer
Jasper Therapeutics, Inc.
CIK 0001788028
Entity typeother
Related Parties
1- filerCIK 0001114916
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 8:40 PM ET
- Size
- 22.1 KB